A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing proteins that may be more effective than the CRISPR-Cas9 systems that underpin most contemporary gene editing therapies.
Photo illustration—Getty Images
He added that the prospective sanctions could remain in place until the two sides come to a ceasefire and peace…
Syrian President Bashar al-Assad has fled the country after a stunning offensive by rebels who seized the capital city of…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
